NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in southern India, with additional investments anticipated, CEO Robert ...

US drug major Amgen on Monday announced the opening of its new technology and innovation site in Hyderabad. The company said it plans to invest $200 million through 2025, with additional ...

Som Chattopadhyay, national executive India, Amgen, said the first 300 employees were hired within 78 days of signing the contract for the new facility and another 300 are to be onboarded soon ...

HYDERABAD, India (Reuters) - U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said ...

Reuters is an international news organisation owned by Thomson Reuters US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase “defensive” as ...

What’s new, what’s different, and what has stayed the same? We’ll find out from each team, continuing after Ed Carpenter Racing with Juncos Hollinger Racing. To understand where the Juncos Hollinger ...

In some places, the ranges of these birds overlap, and they interbreed easily there, so scientists now consider all to be one species – dark-eyed juncos. Each color pattern indicates a subspecies, ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best drug stocks to buy now.

Revenue: US$33.4b (up 19% from FY 2023). Net income: US$4.09b (down 39% from FY 2023). Profit margin: 12% (down from 24% in FY 2023). EPS: US$7.62 (down from US$12.56 in FY 2023). Revenue was in ...